MondegarAI
HHLR ADVISORS, LTD.

Q1 2026 · 13F-HR

HHLR ADVISORS, LTD.holdings as filed

Filed 2026-05-15 · accession 0000919574-26-003551

$1.67B
Reported value
38
Positions
2026-03-31
Period end
View analyzed profile →PRO

The Brief · HHLR ADVISORS, LTD. · Q1 2026

AI · grounded in 13F

HHLR ADVISORS, LTD. established a new position in MRVL valued at $16.9M. The fund also opened new stakes in VIPS for $1.96M and INTC for $1.28M, while increasing its holding of TSM by 37.3%. On the sell side, the fund closed its position in GOOGL for $2.28M and trimmed its holdings in PDD by 61.1% and BABA by 54.8%.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
722304102PDDPDD HOLDINGS INC$425.6M25.4%4,165,029CommonSHARED
01609W102BABAALIBABA GROUP HLDG LTD$307.8M18.4%2,453,657CommonSHARED
07725L102ONCBEONE MEDICINES LTD$307.2M18.4%1,034,306CommonSHARED
36118L106FUTUFUTU HLDGS LTD$194.1M11.6%1,419,483CommonSHARED
52490G102LEGNLEGEND BIOTECH CORP$108.3M6.47%5,984,550CommonSHARED
04272N102AVBPARRIVENT BIOPHARMA INC$90.6M5.42%3,929,117CommonSHARED
482497104BEKEKE HLDGS INC$63.4M3.79%4,236,278CommonSHARED
185123106CWANCLEARWATER ANALYTICS HLDGS I$32.3M1.93%1,365,971CommonSHARED
23285D109CTKBCYTEK BIOSCIENCES INC$29.1M1.74%6,657,030CommonSHARED
573874104MRVLMARVELL TECHNOLOGY INC$16.9M1.01%171,033CommonSHARED
985194208YSGYATSEN HLDG LTD$15.0M0.90%4,885,873CommonSHARED
44975P103NBPNOVABRIDGE BIOSCIENCES$14.7M0.88%5,980,568CommonSHARED
578784100MAZEMAZE THERAPEUTICS INC$10.9M0.65%366,028CommonSHARED
21217B100CTNMCONTINEUM THERAPEUTICS INC$8.7M0.52%669,337CommonSHARED
00851L103APIAGORA INC$7.4M0.44%2,098,553CommonSHARED
G9572D103BULLWEBULL CORP$7.2M0.43%1,500,000CommonSHARED
874039100TSMTAIWAN SEMICONDUCTOR MANUFAC$5.2M0.31%15,520CommonSHARED
786700104SGMTSAGIMET BIOSCIENCES INC$3.8M0.23%724,800CommonSHARED
90114C107TUYATUYA INC$3.6M0.22%1,564,400CommonSHARED
369604301GEGE AEROSPACE$2.8M0.17%10,043CommonSHARED
92763W103VIPSVIPSHOP HLDGS LTD$2.0M0.12%124,700CommonSHARED
608012308MOGUMOGU INC$1.9M0.11%847,510CommonSHARED
38341P102GOSSGOSSAMER BIO INC$1.6M0.10%4,974,041CommonSHARED
458140100INTCINTEL CORP$1.3M0.08%28,970CommonSHARED
69404D108PACBPACIFIC BIOSCIENCES CALIF IN$1.2M0.07%918,892CommonSHARED
29446Y502EQXEQUINOX GOLD CORP$1.2M0.07%80,500CommonSHARED
67066G104NVDANVIDIA CORPORATION$1.2M0.07%6,610CommonSHARED
55024U109LITELUMENTUM HLDGS INC$1.1M0.06%1,500CommonSHARED
219350105GLWCORNING INC$1.0M0.06%7,700CommonSHARED
06849F108BBARRICK MNG CORP$1.0M0.06%25,400CommonSHARED
19247G107COHRCOHERENT CORP$1.0M0.06%4,275CommonSHARED
25445D101DDLDINGDONG CAYMAN LTD$911,0650.05%354,500CommonSHARED
15234Q207AXIACENTRAIS ELET BRAS SA$711,7680.04%63,100CommonSHARED
464286822EWWISHARES INC$662,0240.04%8,800CommonSHARED
01626L204ALGSALIGOS THERAPEUTICS INC$566,5150.03%76,247CommonSHARED
90138A103VNETVNET GROUP INC$546,1890.03%65,100CommonSHARED
91818X306UXINUXIN LTD$58,8090.00%19,156CommonSHARED
G2124G120RDGTRIDGETECH INC$6570.00%20,167CommonSHARED

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.